Celltrion
068270.KS
#789
Rank
โ‚น2.791 T
Marketcap
โ‚น12,758
Share price
4.46%
Change (1 day)
34.99%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2025 (TTM): โ‚น165.10

According to Celltrion 's latest financial reports the company's current EPS (TTM) is โ‚น176.68. an increase over its 2024 EPS that were of โ‚น114.87.

EPS history for Celltrion from 2007 to 2025

Annual EPS

Year EPS Change
2025โ‚น302.87163.66%
2024โ‚น114.87-53.73%
2023โ‚น248.27-2.08%
2022โ‚น253.54-11.72%
2021โ‚น287.202.03%
2020โ‚น281.4882.8%
2019โ‚น153.9818.31%
2018โ‚น130.15-36.33%
2017โ‚น204.42161.25%
2016โ‚น78.252.86%
2015โ‚น76.0717.84%
2014โ‚น64.565.87%
2013โ‚น60.97-70.85%
2012โ‚น209.18134.09%
2011โ‚น89.3643.59%
2010โ‚น62.2374.49%
2009โ‚น35.66317.8%
2008โ‚น8.54-71.7%
2007โ‚น30.16